Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality

Volume: 111, Issue: 4, Pages: 868 - 886
Published: Apr 1, 2022
Abstract
Injectable protein-based medicinal products (drug products, or DPs) must be produced by using sterile manufacturing processes to ensure product safety. In DP manufacturing the protein drug substance, in a suitable final formulation, is combined with the desired primary packaging (e.g., syringe, cartridge, or vial) that guarantees product integrity and enables transportation, storage, handling and clinical administration. The protein DP is...
Paper Details
Title
Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality
Published Date
Apr 1, 2022
Volume
111
Issue
4
Pages
868 - 886
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.